Reports Q4 revenue $481.1M, consensus $470.5M. “2024 was a fantastic year at Hims and Hers as we continue to build a platform that leverages personalization and technology unlike any traditional healthcare system,” said Andrew Dudum, co-founder and CEO. “Over 2 million subscribers now entrust Hims & Hers to aid them in their journey to better health – with thousands more joining daily. In the coming years, we expect to further transform how individuals can improve their health with more comprehensive treatments, technologies that normalize unlimited follow up support, and tools that can eventually be exported beyond Hims and Hers, enabling even more Americans to access this care. We believe an ongoing focus in these areas will allow every household in the country to access high quality, precision care that is convenient and affordable and expect 2025 will be another exciting step toward our vision of this next-generation of healthcare.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HIMS:
- Hims and Hers Health options imply 17.3% move in share price post-earnings
- Options Volatility and Implied Earnings Moves Today, February 24, 2025
- Hims & Hers Health: Navigating Uncertainty with At-Home Lab Testing Expansion
- Hims & Hers Health, Inc. (HIMS) Q4 Earnings Cheat Sheet
- Shortage of Novo Nordisk’s (NVO) Weight Loss Drugs Is Resolved, Says FDA